Maxmed Life Sciences Private Limited

Maxmed Life Sciences Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
CIN U24232DL2004PTC126912 Incorporated 14 June 2004 ROC Delhi HQ Delhi, India
Active Private Limited Company pharma MSME · Medium
Revenue · FY 2023
₹66.13 Cr
▼ 10% YoY
Net profit · FY 2023
₹1.24 Cr
Net margin 1.9%
EBITDA · FY 2023
₹4.66 Cr
EBITDA margin 7.1%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹2.5 Cr
Issued & subscribed
Open charges
₹33.35 Cr
Satisfied ₹1.62 Cr
Company age
22 yrs
Est. 2004
Employees · EPFO
40
Provident fund records

About Maxmed Life Sciences Private Limited

Data last updated:

Maxmed Life Sciences Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 June 2004 and has been in existence for over 22 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2004PTC126912. Its GSTIN is 07AACCK4216H1ZS (Delhi). The company holds 4 GST registrations, of which 2 are active.

The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹2.5 Cr. It was formerly known as Kk Maxmed Private Limited. It is led by directors including Shubham Wasan and Sanjeev Wasan.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at House No.12 Gang Dass Mohalla, Village – Aya Nagar New Delhi, Delhi, India – 110047.

As per the financials filed for FY 2023, the company reported a revenue of ₹66.13 Cr, a decline of 10% compared to the previous year. For the same year it recorded a net profit of ₹1.24 Cr (net margin 1.9%) and EBITDA of ₹4.66 Cr (EBITDA margin 7.1%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years and 3% over five years.

The company has about 40 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Maxmed Lifesciences. As per MCA filings, the company has open charges of ₹33.35 Cr and satisfied charges of ₹1.62 Cr on record. Court records list 34 cases involving the company, including 22 filed by the company and 12 filed against it; 9 cases are pending. The company has 3 deals on record (2 funding rounds, 1 rights issue), with disclosed funding of ₹48 Lakh; the latest was in January 2016. Its 6 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 2 smaller; the largest is Hiral Labs Limited with revenue of ₹66.46 Cr. The company has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 5 overdue payments to 5 micro and small suppliers.

Maxmed Life Sciences Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0006247). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website maxmedlifesciences.com.

Company details

CIN U24232DL2004PTC126912
Registration Number 126912
Incorporation Date 14 June 2004
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-DL-11-0006247

Recognitions & Rankings of Maxmed Life Sciences

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-DL-11-0006247

Contact details

Maxmed Life Sciences Private Limited's registered office is in Delhi, Delhi. Its website is maxmedlifesciences.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    House No.12 Gang Dass Mohalla, Village – Aya Nagar New Delhi, Delhi, India – 110047
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Maxmed Life Sciences Private Limited, buy the company report.

Comprehensive company report
Maxmed Life Sciences Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Maxmed Life Sciences operates one associated brand: Maxmed Lifesciences. Each brand links to its own profile.

BrandDescriptionWebsite
Manufacturer of generic solid and liquid dosage formsmaxmedlifesciences.com

Business activity

The main business activity of Maxmed Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Maxmed Life Sciences Private Limited, buy the company report.

Financials of Maxmed Life Sciences Private Limited

FY 2024 filings available

Maxmed Life Sciences Private Limited reported revenue of ₹66.13 Cr (down 10% YoY) for FY 2023.

Revenue · FY 2023
₹66.13 Cr ▼ 10%
Net profit · FY 2023
₹1.24 Cr margin 1.9%
EBITDA · FY 2023
₹4.66 Cr margin 7.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 10%
3 years · compounded
▲ 1%
5 years · compounded
▼ 3%
EBITDA CAGR growth
1 year
▼ 4%
3 years · compounded
▼ 2%

Revenue has declined at a compounded annual rate (CAGR) of 3% over five years, including a 10% fall in the latest year. EBITDA fell 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹66.13 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹4.66 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.24 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin7.1%
Net Profit Margin1.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Maxmed Life Sciences Private Limited, buy the company report.

Board of directors of Maxmed Life Sciences Private Limited

Maxmed Life Sciences has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Shubham WasanDirector01 Jul 20197 Years 4 MonthsCurrent
Vandana WasanAdditional Director09 Nov 20242 Years 0 MonthsCurrent
Sanjeev WasanDirector14 Jun 200422 Years 5 MonthsCurrent

Peer comparison

Maxmed Life Sciences Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Hiral Labs Limited₹66.46 Cr (FY 2025)6.0%Ahmedabad, Gujarat, India
Skyec Drugs and Pharmaceuticals Private Limited₹66.27 Cr (FY 2025)19.0%Chennai, Tamil Nadu, India
Medizen Labs Private Limited₹66.2 Cr (FY 2023)39.0%Bangalore, Karnataka, India
Bestochem Formulations (India) Limited₹66.17 Cr (FY 2024)5.0%New Delhi, Delhi, India
Maxmed Life Sciences Private Limitedthis company₹66.13 Cr (FY 2023)₹1.24 Cr1.9%-10.0%40Delhi, India
Skymap Healthcare Private Limited₹65.96 Cr (FY 2022)70.0%New Delhi, Delhi, India
Caplet India Pvt.Ltd.₹65.86 Cr (FY 2025)-5.0%Kolkata, West Bengal, India

To see the full peer comparison of Maxmed Life Sciences Private Limited, buy the company report.

Auditor

Maxmed Life Sciences Private Limited is audited by ASHOK SHYAM & ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
ASHOK SHYAM & ASSOCIATESFY 2023011223N

Shareholding

The shareholding of Maxmed Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2021FY 2020FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Maxmed Life Sciences Private Limited, buy the company report.

Charges & borrowings

Open charges
₹33.35 Cr
Satisfied charges
₹1.62 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹17.85 Cr
Others₹15.50 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
26 Nov 2025101189775Hdfc Bank Limited₹7.95 CrOpen
05 Jan 2024100871878Others₹10.5 CrOpen
25 May 2023100755713Hdfc Bank Limited₹30 LakhOpen
30 Sep 2019100293862Others₹5 CrOpen
14 Feb 201510552298Hdfc Bank Limited₹5.95 CrOpen

To see the full charge records of Maxmed Life Sciences Private Limited, buy the company report.

Total charge records: 8 View all charges

Deals & funding

Maxmed Life Sciences Private Limited has 3 deals on record (2 funding rounds, 1 rights issue), with disclosed funding of ₹48 Lakh; the latest was in January 2016.

Total deals
3
Funding rounds
2
Rights issue
1
Disclosed funding
₹48 Lakh

Deals on record (3 of 3)

WhenDealAmountParties
Jan 2016Rights issue₹2 CrInvestors: 2 individuals
Mar 2009Funding round₹35 LakhInvestors: 2 individuals
Mar 2007Funding round₹13 LakhInvestors: 2 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Maxmed Life Sciences Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 5 overdue payments to 5 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 5)

SupplierAmount dueDue sinceReported on
Biochem Laboratries Rudrapur
an individual supplier
Amba Sales & Services Amhedabad-382445
an individual supplier
L&P Sterile Packaging Private Limited

To see the full MSME payment records of Maxmed Life Sciences Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Maxmed Life Sciences Private Limited has a workforce of 40 employees on its EPFO records as of Apr 2026, across 1 active EPFO establishment.

Employee count
40
Active EPFO establishments
1
Employee growth
-11.1%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2740
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Maxmed Life Sciences Private Limited, buy the company report.

GST

Maxmed Life Sciences has 4 GST registrations: 2 active and 2 cancelled or inactive.

Total GSTINs
4
Active
2
Cancelled / inactive
2
GSTINStateStatusRegistered on
07AACCK4216H1ZSDelhiActive01 Jul 2017
05AACCK4216H1ZWUttarakhandActive01 Jul 2017

To see the full GST registrations and return filing status of Maxmed Life Sciences Private Limited, buy the company report.

Recent activity

Maxmed Life Sciences Private Limited has 7 board changes on record since 2004: 3 appointments and 4 cessations. The latest: Vandana Wasan ceased to be Additional Director on 13 May 2025.

Charges
A charge with Hdfc Bank Limited amounted to Rs. 7.95 Cr with Charge ID 101189775 was registered on 26 Nov 2025.
Charges
A charge registered on 03 Oct 2020 via Charge ID 100377554 with Others was fully satisfied on 18 Jun 2025.
Ceased
Vandana Wasan ceased to be Additional Director.
Charges
A charge with Hdfc Bank Limited of Rs. 3.65 Cr registered on 04 Nov 2013 with Charge ID 10462706 was modified on 28 Mar 2025.
Charges
A charge with Others of Rs. 10.50 Cr registered on 05 Jan 2024 with Charge ID 100871878 was modified on 03 Feb 2025.
Appointed
Vandana Wasan was appointed as Additional Director.
Ceased
Shubham Wasan ceased to be Additional Director.
AGM
Maxmed Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Maxmed Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
A charge with Others amounted to Rs. 10.50 Cr with Charge ID 100871878 was registered on 05 Jan 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.30 Cr with Charge ID 100755713 was registered on 25 May 2023.
Ceased
Dharmendra Kumar Singh ceased to be Whole-Time Director.

10 earlier events are in the company report.

Frequently asked questions

Maxmed Life Sciences is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 June 2004 (22+ years old) and is registered under CIN U24232DL2004PTC126912.

Maxmed Life Sciences has 3 current directors:

The latest financial statements of Maxmed Life Sciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Maxmed Life Sciences is 07AACCK4216H1ZS, registered in Delhi. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 05AACCK4216H1ZW (Uttarakhand).

The CIN (Corporate Identification Number) of Maxmed Life Sciences is U24232DL2004PTC126912. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Maxmed Life Sciences has 34 court cases on record: 22 filed by the company and 12 filed against it. 9 are pending. Most are in the district courts.

Maxmed Life Sciences was incorporated on 14 June 2004, making it 22+ years old. It is registered with the Registrar of Companies, Delhi.

Maxmed Life Sciences has 3 deals on record (2 funding rounds, 1 rights issue), with disclosed funding of ₹48 Lakh; the latest was in January 2016.

The peers of Maxmed Life Sciences by revenue are Hiral Labs Limited, Skyec Drugs and Pharmaceuticals Private Limited, Medizen Labs Private Limited, Bestochem Formulations (India) Limited, Skymap Healthcare Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Vandana Wasan ceased to be Additional Director on 13 May 2025. Vandana Wasan was appointed as Additional Director on 09 Nov 2024. Shubham Wasan ceased to be Additional Director on 31 Oct 2024. Maxmed Life Sciences has 7 board changes on record in total.

Yes, Maxmed Life Sciences is registered as a medium enterprise under Udyam registration (number: UDYAM-DL-11-0006247).

Maxmed Life Sciences has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 5 overdue payments to 5 micro and small suppliers. The latest return was filed on 08 Jun 2019.